We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.99T
$309M 2.73%
10,918,096
-618,820
-5% -$16.4M
IDXX icon
2
Idexx Laboratories
IDXX
$44.9B
$252M 2.23%
2,239,499
-83,195
-4% -$8.77M
V icon
3
Visa
V
$707B
$245M 2.16%
2,957,392
+56,835
+2% +$4.55M
AMZN icon
4
Amazon
AMZN
$2.45T
$212M 1.87%
5,053,080
+25,800
+0.5% +$987K
SBUX icon
5
Starbucks
SBUX
$118B
$207M 1.83%
3,829,103
+109,657
+3% +$6.13M
MSFT icon
6
Microsoft
MSFT
$2.93T
$163M 1.44%
2,837,501
+71,102
+3% +$4.01M
GILD icon
7
Gilead Sciences
GILD
$166B
$143M 1.27%
1,812,193
-557,985
-24% -$45.3M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.08T
$141M 1.24%
3,621,920
+55,860
+2% +$2.12M
META icon
9
Meta Platforms (Facebook)
META
$1.5T
$128M 1.13%
999,651
+26,534
+3% +$3.29M
MA icon
10
Mastercard
MA
$501B
$125M 1.11%
1,231,880
+29,502
+2% +$2.83M
FAST icon
11
Fastenal
FAST
$54.4B
$122M 1.08%
11,710,144
-583,972
-5% -$6.21M
RHT
12
DELISTED
Red Hat Inc
RHT
$116M 1.03%
1,440,865
+43,347
+3% +$3.22M
DHR icon
13
Danaher
DHR
$142B
$113M 1%
1,632,444
-399,716
-20% -$28.3M
ZTS icon
14
Zoetis
ZTS
$33B
$112M 0.99%
2,162,235
+252,224
+13% +$12.8M
ADBE icon
15
Adobe
ADBE
$104B
$111M 0.98%
1,020,025
-1,203
-0.1% -$121K
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
$108M 0.95%
1,337,760
+20,020
+2% +$1.63M
CERN
17
DELISTED
Cerner Corp
CERN
$107M 0.94%
1,729,873
+10,170
+0.6% +$642K
AMG icon
18
Affiliated Managers Group
AMG
$9.59B
$105M 0.93%
727,394
-10,979
-1% -$1.57M
DXCM icon
19
DexCom
DXCM
$29.3B
$99.1M 0.88%
4,523,956
+122,952
+3% +$2.74M
ECL icon
20
Ecolab
ECL
$79B
$97.9M 0.87%
804,400
+25,025
+3% +$3.02M
SLB icon
21
SLB Ltd
SLB
$73.9B
$97.3M 0.86%
1,237,176
-24,660
-2% -$1.96M
GE icon
22
GE Aerospace
GE
$368B
$89.3M 0.79%
628,833
+22,449
+4% +$3.35M
BMY icon
23
Bristol-Myers Squibb
BMY
$130B
$88.7M 0.78%
1,645,463
-144,120
-8% -$9.26M
WDAY icon
24
Workday
WDAY
$41B
$86.9M 0.77%
947,231
+36,393
+4% +$3.03M
EOG icon
25
EOG Resources
EOG
$77.4B
$86.4M 0.76%
893,312
+5,895
+0.7% +$518K
1
2 3 4 5

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.